Massachusetts-based firm accuses rival and its partner of copyright infringement, filing suit in both US and German courts

New COVID variants inevitable, Ugur Sahin warns, but the world is 'learning more' and getting a 'better understanding on how to deal with the virus'

Regulators urging drugmaker to apply for emergency authorization of 2-dose regimen of shot for kids aged 6 months to 5 years old while awaiting data on 3-dose course

Pharmaceutical company says it is also examining using a higher dose of its existing vaccine against new strain

Firm that developed vaccine with Pfizer says it will have more data available next month, but has plans in motion to be able to mass-manufacture adapted inoculation

Nanoparticles, tested on mice and unveiled in peer-reviewed research, head straight to cells that are inflamed, and either ‘silence’ or edit the gene that is causing inflammation

European Medicines Agency says it will carry out 'accelerated assessment of data' on shot when submitted by its producers

Ugur Sahin, co-founder of company that jointly developed leading COVID-19 inoculation, says shots have proved effective against other similar mutations

German company on track to manufacture 25% more shots than initially expected, including 250 million in the first half of 2021

BioNTech's Ozlem Tureci says the know-how behind revolutionary inoculations could soon be used to treat far more than the coronavirus pandemic